Biblio print

Tree Display

AceDB Schema

XML Display


Author Report for: Grinan-Ferre C

No contact information in database for Grinan-Ferre C

    Title: Neuroprotective Epigenetic Changes Induced by Maternal Treatment with an Inhibitor of Soluble Epoxide Hydrolase Prevents Early Alzheimer's Disease Neurodegeneration
    Bartra C, Irisarri A, Villoslada A, Corpas R, Aguirre S, Garcia-Lara E, Sunol C, Pallas M, Grinan-Ferre C, Sanfeliu C
    Ref: Int J Mol Sci, 23:, 2022 : PubMed


    Title: Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease
    Codony S, Pont C, Grinan-Ferre C, Di Pede-Mattatelli A, Calvo-Tusell C, Feixas F, Osuna S, Jarne-Ferrer J, Naldi M and Munoz-Torrero D <11 more author(s)>
    Ref: Journal of Medicinal Chemistry, 65:4909, 2022 : PubMed


    Title: Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication for Soluble Epoxide Hydrolase Inhibitors
    Codony S, Entrena JM, Calvo-Tusell C, Jora B, Gonzalez-Cano R, Osuna S, Corpas R, Morisseau C, Perez B and Vazquez S <13 more author(s)>
    Ref: Journal of Medicinal Chemistry, 65:13660, 2022 : PubMed


    Title: A Combined Chronic Low-Dose Soluble Epoxide Hydrolase and Acetylcholinesterase Pharmacological Inhibition Promotes Memory Reinstatement in Alzheimer's Disease Mice Models
    Jarne-Ferrer J, Grinan-Ferre C, Bellver-Sanchis A, Vazquez S, Munoz-Torrero D, Pallas M
    Ref: Pharmaceuticals (Basel), 15:, 2022 : PubMed


    Title: From the Design to the In Vivo Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors for the Treatment of Acute Pancreatitis
    Codony S, Calvo-Tusell C, Valverde E, Osuna S, Morisseau C, Loza MI, Brea J, Perez C, Rodriguez-Franco MI and Vazquez S <8 more author(s)>
    Ref: Journal of Medicinal Chemistry, :, 2021 : PubMed


    Title: Inhibition of Soluble Epoxide Hydrolase Ameliorates Phenotype and Cognitive Abilities in a Murine Model of Niemann Pick Type C Disease
    Grinan-Ferre C, Companys-Alemany J, Jarne-Ferrer J, Codony S, Gonzalez-Castillo C, Ortuno-Sahagun D, Vilageliu L, Grinberg D, Vazquez S, Pallas M
    Ref: Int J Mol Sci, 22:, 2021 : PubMed


    Title: From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects
    Pont C, Ginex T, Grinan-Ferre C, Scheiner M, Mattellone A, Martinez N, Arce EM, Soriano-Fernandez Y, Naldi M and Munoz-Torrero D <13 more author(s)>
    Ref: Eur Journal of Medicinal Chemistry, 225:113779, 2021 : PubMed


    Title: Disease-modifying treatment with I2 imidazoline receptor ligand LSL60101 in an Alzheimer's disease mouse model: A Comparative study with donepezil
    Vasilopoulou F, Rodriguez-Arevalo S, Bagan A, Escolano C, Grinan-Ferre C, Pallas M
    Ref: British Journal of Pharmacology, :, 2021 : PubMed


    Title: Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease
    Grinan-Ferre C, Codony S, Pujol E, Yang J, Leiva R, Escolano C, Puigoriol-Illamola D, Companys-Alemany J, Corpas R and Galdeano C <8 more author(s)>
    Ref: Neurotherapeutics, :, 2020 : PubMed


    Title: Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson's Disease: A New Therapeutic Strategy
    Pallas M, Vazquez S, Sanfeliu C, Galdeano C, Grinan-Ferre C
    Ref: Biomolecules, 10:, 2020 : PubMed


Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page

Acknowledgements and disclaimer